πŸ“£ VC round data is live. Check it out!

Jushi Holdings Valuation Multiples

Discover revenue and EBITDA valuation multiples for Jushi Holdings and similar public comparables like Ascend Wellness Holdings, Grown Rogue International, Ispire Technology, Cannara Biotech and more.

Jushi Holdings Overview

About Jushi Holdings

Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature’s Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.


Founded

2007

HQ

United States

Employees

1.2K

Financials (LTM)

Revenue: $267M
EBITDA: $51M

EV

$370M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Jushi Holdings Financials

Jushi Holdings reported last 12-month revenue of $267M and EBITDA of $51M.

In the same LTM period, Jushi Holdings generated $118M in gross profit, $51M in EBITDA, and had net loss of ($60M).

Revenue (LTM)


Jushi Holdings P&L

In the most recent fiscal year, Jushi Holdings reported revenue of β€” and net income of β€”.

See analyst estimates for Jushi Holdings
LTM2025202620272028
Revenue$267M$263M
Gross Profit$118M$114M
Gross Margin44%43%
EBITDA$51M$50M
EBITDA Margin19%19%
EBIT Margin4%2%
Net Profit($60M)($69M)
Net Margin(23%)(26%)

Financial data powered by Morningstar, Inc.

Jushi Holdings Stock Performance

Jushi Holdings has current market cap of $101M, and enterprise value of $370M.

Market Cap Evolution


Jushi Holdings' stock price is $0.50.

Jushi Holdings share price decreased by 2.8% in the last 30 days, and increased by 74.0% in the last year.

See more trading valuation data for Jushi Holdings
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$370M$101M0.0%-2.8%3.0%74.0%β€”

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Jushi Holdings Valuation Multiples

Jushi Holdings trades at 1.4x EV/Revenue multiple, and 7.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Jushi Holdings

EV / Revenue (LTM)


Jushi Holdings Financial Valuation Multiples

As of May 20, 2026, Jushi Holdings has market cap of $101M and EV of $370M.

Jushi Holdings has a P/E ratio of (1.7x).

LTM2025202620272028
EV/Revenue1.4x1.4x
EV/EBITDA7.3x7.4x
EV/EBIT30.9x65.7x
EV/Gross Profit3.1x3.2x
P/E(1.7x)(1.5x)
EV/FCF(223.2x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Jushi Holdings Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Jushi Holdings Margins & Growth Rates

See estimated margins and future growth rates for Jushi Holdings

Jushi Holdings Margins

20252026202720282029
Gross Margin43%45%
EBITDA Margin19%19%
EBIT Margin2%8%
Net Margin(26%)(17%)
FCF Margin(0%)(2%)

Jushi Holdings Growth Rates

25/2626/2727/2828/29
Revenue Growth4%
Gross Profit Growth8%
EBITDA Growth4%
EBIT Growth294%
Net Profit Growth(31%)
FCF Growth2940%

Data powered by FactSet, Inc. and Morningstar, Inc.

Jushi Holdings Operational KPIs

Jushi Holdings' Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Jushi Holdings' Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Jushi Holdings
LTMLast FY2025202620272028
Rule of 4030%23%β€”
Bessemer Rule of X47%28%β€”
G&A Expenses to Revenue34%β€”33%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Jushi Holdings Competitors

Jushi Holdings competitors include Ascend Wellness Holdings, Grown Rogue International, Ispire Technology, Cannara Biotech, Organigram Global, Planet 13, WM Tech, MariMed, iAnthus Capital Holdings and SynBiotic.

Most Jushi Holdings public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ascend Wellness Holdingsβ€”1.3xβ€”5.7x
Grown Rogue Internationalβ€”β€”β€”β€”
Ispire Technology0.9x1.1x(3.4x)(34.9x)
Cannara Biotech1.7x1.6x6.5x6.1x
Organigram Global0.8x0.7x11.1x9.0x
Planet 13β€”1.0xβ€”(13.8x)
WM Techβ€”0.0xβ€”0.2x
MariMedβ€”0.7xβ€”6.6x

This data is available for Pro users. Sign up to see all Jushi Holdings competitors and their valuation data.

Start Free Trial

Jushi Holdings Funding History

Before going public, Jushi Holdings raised $68M in total equity funding, across 1 round.


Jushi Holdings Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jun-19Undisclosed stageβ€”$68Mβ€”Jushi Holdings Inc. is a vertically integrated multi-state cannabis operator focused on organic build-outs in key markets such as Pennsylvania, Nevada, Ohio, Illinois, California, and Virginia. In December 2019, the company announced a US$27.46 million debt financing led by insiders and founders committing US$18.5 million to provide working capital for growth investments and operations. Pro forma for this financing, Jushi projected Q4 2020 run-rate revenue of US$150-180 million and 2021 calendar year revenue of US$200-250 million, excluding additional license wins. For full year 2019, Jushi reported total revenue of $10.2 million and gross profit of $4.8 million, with Q4 2019 revenue at $6.0 million (up 68% sequentially from Q3) and gross profit of $2.7 million. Adjusted EBITDA loss was $(11.2) million for 2019 and $(5.2) million for Q4 2019. As of December 31, 2019, the balance sheet showed $51.2 million in cash and securities, net working capital of $30.6 million, following a minority interest sale in a New York medical marijuana license for $15-20 million and opening a sixth dispensary in Pennsylvania.

Jushi Holdings M&A Activity

Jushi Holdings has acquired 9 companies to date.

Last acquisition by Jushi Holdings was on March 17th 2022. Jushi Holdings acquired The Apothecarium for $21M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Jushi Holdings

The Apothecarium
NuLeaf
OhiGrow
Nature's Remedy
Description
The Apothecarium is a licensed medical cannabis dispensary in San Francisco's Castro district. It supplies patients with flowers, edibles, topicals, and concentrates in a secure environment accessible by foot, bike, public transit, or car. Patient consultants guide selections based on medical needs, ensuring compliance with California regulations. The dispensary maintains membership-based access and focuses on quality-controlled products from licensed cultivators.
NuLeaf is a Las Vegas-based vertically integrated cannabis operator licensed in Nevada with cultivation, manufacturing, and retail dispensaries. Operating since 2017, it manages 10,000 square feet of grow facilities producing flower, edibles, and extracts sold through five stores in the Las Vegas valley. NuLeaf supplies premium strains to medical and recreational markets, achieving $20 million in annual revenue amid state expansion.
OhiGrow is a licensed medical marijuana cultivator in Ohio among 34 state-approved facilities. It supplies biomass to processing plants for manufactured cannabis products sold into the wholesale market serving Ohio's medical program.
Nature’s Remedy is a Lakeville-based vertically integrated cannabis company in Massachusetts that cultivates flower and manufactures infused products including edibles and topicals. Its dispensaries operate in Millbury and Tyngsboro, while products reach additional marijuana facilities statewide. The company emphasizes medical-grade quality with on-site production facilities supporting a range of strains and formats for recreational and medical consumers.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
San Francisco, CA
Las Vegas, NV
Toledo, OH
Worcester, MA
Deal Date17 Mar 202217 Nov 202120 Apr 202119 Apr 2021
Valuation$21M$63M$5M$91M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Jushi Holdings acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Jushi Holdings

When was Jushi Holdings founded?Jushi Holdings was founded in 2007.
Where is Jushi Holdings headquartered?Jushi Holdings is headquartered in United States.
How many employees does Jushi Holdings have?As of today, Jushi Holdings has over 1K employees.
Who is the CEO of Jushi Holdings?Jushi Holdings' CEO is James A. Cacioppo.
Is Jushi Holdings publicly listed?Yes, Jushi Holdings is a public company listed on OTC Pink Sheets.
What is the stock symbol of Jushi Holdings?Jushi Holdings trades under JUSHF ticker.
Who are competitors of Jushi Holdings?Jushi Holdings main competitors include Ascend Wellness Holdings, Grown Rogue International, Ispire Technology, Cannara Biotech, Organigram Global, Planet 13, WM Tech, MariMed, iAnthus Capital Holdings, SynBiotic.
What is the current market cap of Jushi Holdings?Jushi Holdings' current market cap is $101M.
What is the current revenue of Jushi Holdings?Jushi Holdings' last 12 months revenue is $267M.
What is the current revenue growth of Jushi Holdings?Jushi Holdings revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Jushi Holdings?Current revenue multiple of Jushi Holdings is 1.4x.
Is Jushi Holdings profitable?Yes, Jushi Holdings is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Jushi Holdings?Jushi Holdings' last 12 months EBITDA is $51M.
What is Jushi Holdings' EBITDA margin?Jushi Holdings' last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Jushi Holdings?Current EBITDA multiple of Jushi Holdings is 7.3x.
What is the current FCF of Jushi Holdings?Jushi Holdings' last 12 months FCF is ($2M).
What is Jushi Holdings' FCF margin?Jushi Holdings' last 12 months FCF margin is (1%).
What is the current EV/FCF multiple of Jushi Holdings?Current FCF multiple of Jushi Holdings is (223.2x).
How many companies Jushi Holdings has acquired to date?As of May 2026, Jushi Holdings has acquired 9 companies.
What was the largest acquisition by Jushi Holdings?$91M acquisition of Nature's Remedy on 19th April 2021 was the largest M&A Jushi Holdings has done to date.
What companies Jushi Holdings acquired?Jushi Holdings acquired Nature's Remedy, Franklin Bioscience – Penn LLC, NuLeaf, Pennsylvania Medical Solutions, Dalitso LLC, The Apothecarium, OhiGrow, Medicinal Excellence in Neurological Disorders, LLC, and Agape Total Healthcare.
In how many companies Jushi Holdings has invested to date?Jushi Holdings hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Jushi Holdings

Lists including Jushi Holdings

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial